Comparative Oncology

Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.

Jason Sheltzer, a research fellow at Cold Spring Harbor Laboratory, and his team have examined prostate, breast, lung and other forms of cancer, with an emphasis toward prognosis and predictability.

Who needs lab rats when you’ve got dogs?

Read about Northwestern biomedical engineering professor Vadim Backman's discovery of a new strategy that might help save thousands of lives through the early detection of cancer. Backman also pioneered an effective new treatment that combines chemotherapy and chromatin therapeutics.

Glioblastoma is the deadliest brain cancer in people. It's the cancer that claimed the lives of Senators John McCain and Ted Kennedy. Now an experimental drug being tested on dogs could hold promise for people.

Scientists explore interspecies variations, hoping to find better ways of treating or preventing the disease in humans.

“Our results are consistent and repeatable.”

Despite skepticism, researchers remain doggedly determined to nosing out disease.

The field of comparative oncology leverages other mammals’ cancers, even some from cats and horses, to develop better human treatments.

Most of the 800 veterinarians surveyed feel ethical qualms when pet owners ask them to euthanize animals that could be treated, or when owners ask to keep pets alive who will suffer needlessly.

Recent research suggests that chemotherapy can help horses with lymphoma achieve remission and extend their lifespans for several months or years.

You'd think elephants would be getting cancer left and right, but they have evolved resistance. They're being studied for clues about how to treat cancer in humans.

An ambitious study is tracking thousands of these popular pooches for their entire lives, and it could lead to breakthroughs in canine cancer prevention.